Literature DB >> 12706451

Lidocaine block of neonatal Nav1.3 is differentially modulated by co-expression of beta1 and beta3 subunits.

Paul W Lenkowski1, Bhaval S Shah, Andrew E Dinn, Kevin Lee, Manoj K Patel.   

Abstract

The effects of lidocaine on neonatal Na(v)1.3 (Na(v)1.3n) expressed alone and in combination with beta1 and beta3 subunits in Xenopus oocytes were examined. Lidocaine reversibly inhibited the peak Na(v)1.3n current, shifted the steady-state inactivation curve to hyperpolarized potentials and delayed recovery from inactivation. These effects were attenuated by the co-expression of the beta subunits, with greater attenuating effects being observed in oocytes co-expressing beta1 compared to those co-expressing beta3. Use-dependent block by lidocaine was assessed at 1 Hz train frequency for 60 pulses. Lidocaine caused similar use-dependent block of current amplitude at pulse 60 for Na(v)1.3n and Na(v)1.3n+beta3. In oocytes co-expressing beta1, these use-dependent actions were reduced. In conclusion, the effects of lidocaine on Na(v)1.3n are differentially modulated by beta1 and beta3 subunits. Since these subunits exhibit a complementary distribution, this finding may have importance in our understanding of lidocaine action.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706451     DOI: 10.1016/s0014-2999(03)01595-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  18 in total

1.  Sodium channel Na(V)1.5 expression is enhanced in cultured adult rat skeletal muscle fibers.

Authors:  J Morel; F Rannou; H Talarmin; M A Giroux-Metges; J P Pennec; G Dorange; G Gueret
Journal:  J Membr Biol       Date:  2010-06-02       Impact factor: 1.843

2.  Distinct domains of the sodium channel beta3-subunit modulate channel-gating kinetics and subcellular location.

Authors:  Esther J Yu; Seong-Hoon Ko; Paul W Lenkowski; Alena Pance; Manoj K Patel; Antony P Jackson
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

Review 3.  Voltage-gated sodium channel β subunits: The power outside the pore in brain development and disease.

Authors:  Jacob M Hull; Lori L Isom
Journal:  Neuropharmacology       Date:  2017-09-18       Impact factor: 5.250

4.  PHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLD.

Authors:  R Salvi; E Lobarinas; W Sun
Journal:  Drugs Future       Date:  2009       Impact factor: 0.148

Review 5.  Electrophysiology and beyond: multiple roles of Na+ channel β subunits in development and disease.

Authors:  Gustavo A Patino; Lori L Isom
Journal:  Neurosci Lett       Date:  2010-06-23       Impact factor: 3.046

6.  Crystallographic insights into sodium-channel modulation by the β4 subunit.

Authors:  John Gilchrist; Samir Das; Filip Van Petegem; Frank Bosmans
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

Review 7.  Emerging pharmacotherapy of tinnitus.

Authors:  Berthold Langguth; Richard Salvi; Ana Belén Elgoyhen
Journal:  Expert Opin Emerg Drugs       Date:  2009-12       Impact factor: 4.191

8.  Voltage-dependent blockade by bupivacaine of cardiac sodium channels expressed in Xenopus oocytes.

Authors:  Heng Zhang; Hui Ji; Zhirui Liu; Yonghua Ji; Xinmin You; Gang Ding; Zhijun Cheng
Journal:  Neurosci Bull       Date:  2014-07-09       Impact factor: 5.203

9.  Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 : Differential activities of Nav1.7-targeting monoclonal antibodies.

Authors:  Sangsu Bang; Jiho Yoo; Xingrui Gong; Di Liu; Qingjian Han; Xin Luo; Wonseok Chang; Gang Chen; Sang-Taek Im; Yong Ho Kim; Judith A Strong; Ma-Zhong Zhang; Jun-Ming Zhang; Seok-Yong Lee; Ru-Rong Ji
Journal:  Neurosci Bull       Date:  2018-01-15       Impact factor: 5.203

10.  Coexpression with Auxiliary β Subunits Modulates the Action of Tefluthrin on Rat Na(v)1.6 and Na(v)1.3 Sodium Channels.

Authors:  Jianguo Tan; Jin Sung Choi; David M Soderlund
Journal:  Pestic Biochem Physiol       Date:  2011-10-17       Impact factor: 3.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.